A screening tool for therapeutic monoclonal antibodies: Identifying the most stable protein and its best formulation based on thioflavin T binding
Version of Record online: 21 NOV 2011
Copyright © 2012 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim
Special Issue: Biotech Methods and Advances
Volume 7, Issue 1, pages 127–132, January 2012
How to Cite
Kayser, V., Chennamsetty, N., Voynov, V., Helk, B., Forrer, K. and Trout, B. L. (2012), A screening tool for therapeutic monoclonal antibodies: Identifying the most stable protein and its best formulation based on thioflavin T binding. Biotechnology Journal, 7: 127–132. doi: 10.1002/biot.201100366
- Issue online: 9 JAN 2012
- Version of Record online: 21 NOV 2011
- Accepted manuscript online: 26 SEP 2011 06:55AM EST
- Manuscript Accepted: 13 SEP 2011
- Manuscript Revised: 7 SEP 2011
- Manuscript Received: 20 JUL 2011
- Novartis. Grant Number: 6899090
Detailed facts of importance to specialist readers are published as ”Supporting Information”. Such documents are peer-reviewed, but not copy-edited or typeset. They are made available as submitted by the authors.
Please note: Wiley Blackwell is not responsible for the content or functionality of any supporting information supplied by the authors. Any queries (other than missing content) should be directed to the corresponding author for the article.